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Pheochromocytoma, (PCC) is a sympathetic paraganglioma of chromafﬁn cell origin. Individuals with
PCC, present with signs and symptoms of sympathetic overstimulation. In this article, we report a case
of a 10-year-old male presenting with hypertensive encephalopathy precipitated by bilateral adrenal
PCC. A 10 year old, male patient who presented to Emergency Department with history of headache,
projectile vomiting, disturbed level of consciousness and two attacks of convulsion for one day. PCC are
catecholamine secreting tumors. In the case we are describing, adrenoceptor overstimulation man-
ifested as uncontrolled hypertension which progressed to hypertensive encephalopathy. Only 10% of
PCC’s cases were found to be bilateral. Though bilateral PCC is more often a part of a familial syndrome,
in this case, we report bilateral PCC with no evidence of familial disorders that correlates with this
presentation. Preoperative diagnosis is usually made by signiﬁcantly high levels of catecholamines and
their metabolites in blood and urine. In recent studies, using (131-I-MIBG, metaiodobenzylguanidine
scan), in combination with platelet normetanephrin, showed 100% sensitivity in detecting PCC.
Deﬁnitive treatment of PCC is surgical resection of the mass which is considered to be curative in 90%
of the cases. Following Cortex sparing Bilateral Adrenalectomy, the patient showed complete resolution
of hypertension. PCC should be considered as a possible diagnosis in children presenting with ma-
lignant hypertension. Stabilize blood pressure is important part in the preoperative period. Adrenal
sparing surgery showed promising outcomes in treating cases of bilateral PCC.
 2014 The Authors. Published by Elsevier Inc. All rights reserved.Pheochromocytomas is a sympathetic paraganglioma that
originates from chromafﬁn cell. The reported incidence of PCC is
about 2e8 cases per million [1,2]. Individuals with PCC, present
with signs and symptoms of sympathetic overstimulation. Aware-
ness of the classic triad of tachycardia, episodic headache and
sweating, is a key to early recognition of this condition [3]. Despite
the advanced diagnostic tools including chemical and imaging in-
vestigations and with patient’s late presentation, the early diag-
nosis of PCC may still be missed in some cases. In this article, we
report a case of a 10-year-old male presenting with hypertensive
encephalopathy precipitated by Bilateral Pheochromocytoma.1. Case presentation
We report a 10-year-old male, who presented to the Emergency
Department at King Abdulaziz University Hospital with history ofBY-NC-ND license (http://
Hospital, P.O. Box 1716, Zip
Published by Elsevier Inc. All rightheadache, projectile vomiting disturbed level of consciousness for
one day. He had a history of two attacks of convulsion. The patient
had positive history of fever, but not documented. No history of
photophobia nor trauma. He had negative history of contact with
sick patient. No family history of seizure disorder. In the Emergency
department the patient had very high blood pressure with readings
around 180/80-90. Otherwise physical examination was unre-
markable. No sign of meningism.
Full Septic screen was negative. Complete Blood Count and Urea
& Electrolytes were within normal. Serum calcium, phosphate and
Parathyroid Hormone were normal. Thyroid function test was
normal. ASO, Antistreptolysin O titre was 404 units/ml. ANA,
Antinuclear Antibody was negative.
In the ED patient was given diazepam and loading dose of
phenytoin and the convulsions were controlled. While, high blood
pressure was managed by nifedipine and IV infusion of labetalol.
CT scan of brain and ECHO were both normal. CT abdomen
showed bilateral heterogenous enhanced adrenal lesions with
central hypodensities, (Fig. 1A, B). With the given clinical history of
uncontrolled hypertension, we made a provisional diagnosis of
hypertensive encephalopathy secondary to adrenal pheochromo-
cytoma. He was admitted to Pediatric Intensive Care Unit. For
conﬁrming this diagnosis we did 24 h urinary collection fors reserved.
Fig. 1. A: CT e Abdominal angiography showing Bilateral enlarged suprarenal masses, the right to suprarenal mass measuring 4.2  2.5 cm, the left suprarenal mass measuring
3.7  2.6 cm. The adrenal glands are not to visualized which supports the origin of these lesions which demonstrate strong heterogenous arterial enhancement, some calciﬁcation
with the central hypodensities ranging between 37e57 Hounsﬁeld unit. No invasion into the adjacent structures. Both kidneys has normal size and cortical density. Each kidney is
supply by single artery, no stenosis or plaque formation. B: CT- Abdominal Angiography (Transverse section of the abdomen). Heterogenously enhanced adrenal lesions with central
hypodensities and with giving clinical history of uncontrolled hypertension, bilateral pheochromocytoma is most likely diagnosis.
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compatible with pheochromocytoma.
MIBG Scan was also performed and showed high uptake in
supra-renal glands in both sides but no metastasis. A pediatric
surgeon was contacted and operation for tumor resection was
planned. Patient was prepared for surgery with collaboration with
Anesthesiologist. Patient was given Prazosin (an alpha blocker)
preoperatively, starting with 2.5 mg Q6 hours. Patient was also
given Amlodipine 10 mg once daily and Atenolol (a beta blocker)
20 mg two times daily. His blood pressure was around 113e117/
50e55 mmHg. Last dose of drugs were given on the morning of the
day of surgery. The patient was taken to operating room. Via lap-
arotomy, the right adrenal mass was enucleated with remaining
some adrenal cortex. On the left side, there were two adrenal
masses which were both enucleated and residual adrenal cortex
was left as well. Post operation he was admitted to Pediatric ICU
and kept under observation.
Postoperative recovery was uneventful and patient was vitally
stable and discharged on the seventh day following operation.
Histopathology report revealed well circumscribed neoplastic
growth composed of well-deﬁned nets bounded by delicate ﬁbro-
vascular strom. The cells are polygonal with oval to round nuclei,
prominent nucleoli and granular cytoplasm. The histopathology
report conﬁrmed the diagnosis of Bilateral Pheochromocytoma.
Following the procedure, the patient was followed up in
outpatient settings and BP was checked at regular intervals. He
showed fast recovery with complete resolution of hypertension. In
addition, no steroids were required.
2. Discussion
Pheochromocytoma (PCC), is a rare tumor, originating from the
suprarenal medulla and sympathoadrenal neuroendocrine system.
The reported incidence of pheochromocytomas is about 2e8 cases
per million [1,2]. 10e20% of these cases occur in pediatric age group
[3]. These tumors produce and secrete catecholamines (epinephrine,
nor epinephrine and dopamine). Due to the signiﬁcant rise in cate-
cholamine levels, patients having PCC present with various symp-
toms and signs of adrenoceptoroverstimulation. Therefore, sustained
or paroxysmal Hypertension, palpitation, diaphoresis and headache
strongly suggest the presence of PCC, with a 94% speciﬁcity and 91%
sensitivity [4]. However, pediatric patientswithPCCpresent clinically
with sustained hypertension instead of classical triad [2].
Pheochromocytoma is rare cause of hypertension in pediatric
age group. Only 0.1% of hypertension patients were found to have
PCC [5]. Malignant hypertension characterized by symptomaticelevations of blood pressure can be a clinical feature of malignant
pheochromocytoma [6]. Most PCC are localized within the
abdomen and in about 90% of the cases it’s adrenal in origin [4].
Adrenal pheochromocytomas aremost often found on the right side
and are unilateral, sporadic and benign. 20% of PCC’s cases were
found to be Bilateral.
In a recent study, it was found that about (6.7%) of patients with
PCC were associated with familial syndromes [5]. Interestingly in
271 patients presented with non-syndromic pheochromocytoma
andwithout family history, 66 patients (24%) found to have positive
genetic mutation. Patients with positive genetic mutation were
likely to be young at presentation, have bilateral disease [7].
In pediatric age group, bilateral pheochromocytoma is more
often part of a familial syndrome [8,9], such as neuro-ﬁbroma-
tosis, von Hippel-Lindau disease, tuberous sclerosis, and Sturge-
Weber syndrome, and as a component of multiple endocrine
neoplasia (MEN 2). In France a rare case of bilateral PCC related to
HIF2A gene has been reported in a female neonate presented with
polycythemia [10]. Kalish et al., has reported a bilateral PCC in 18-
month old female who is diagnosed initially with hemi-
hyperplasia at the age of 4 months and found to have mosaic
chromosome 11p15 paternal uniparental isodisomy (UPD) [11].
In this case, we report bilateral PCC with no evidence of familial
correlation and the patient was screened for the previously
mentioned disorders. Our patient was examined for signs indi-
cating Familial diseases such as NF, which was clinically excluded
by the absence of Café au lait spots. In order to role out MEN
syndrome, Serum calcium, PTH and calcitonin were investigated
and turned out to be normal. In addition, negative family history of
any similar cases, helped in the process of excluding possible fa-
milial etiology. Around 25% of all PCC cases are discovered inci-
dentally during imaging studies for unrelated disorders [12]. In
addition to clinical presentation, preoperative diagnosis is usually
made by signiﬁcantly high levels of catecholamines and their
metabolites in blood and urine. 24-hour urine collection for urine
catecholamines is both sensitive and speciﬁc [13] but it might be a
cumbersome test in young and small children. Using receiver
operating characteristic curves, the highest sensitivity and speci-
ﬁcity values were reported for plasma free metanephrines [14].
Combining different tests did not improve the diagnostic yield
beyond that of a single test of plasma free metanephrines. Recent
studies show a higher sensitivity for the determination of 24-h
urine normetanephrine and platelet nor epinephrine [15].
Computed tomography scan and magnetic resonance imaging
are used in diagnosing and localizing PCC, with a sensitivity
of 75%e100%, though with low speciﬁcity. The (131-I-MIBG),
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with platelet normetanephrin, has (100%) sensitivity. In compar-
ison to 131-I-MIBG, PET scan, Positron emission tomography scan
has a better image resolution and using tracer (18-ﬂuoro-dihy-
droxyphenylalanine), its sensitivity reaches about 100% [16].
Deﬁnitive treatment of PCC is surgical resection of the mass which
is considered to be curative in 90% of the cases [17]. Anesthesia
preparation can be difﬁcult in terms of maintaining stable he-
modynamic in patients with PCC. The patient’s status should be
optimized, blood pressure controlled and blood volume repletion
are accomplished in order to prepare the patient for the operation.
In order to prevent hypertensive crisis, Alpha-adrenergic
blockade, in particular, is used for BP control. An initial dose of
20 mg of phenoxybenzamine is given to the patient with daily
increase by 10 mg until 160 mg is reached, aiming to orthostatic
hypotension [18].
In cases where the patient has tachycardia or arrhythmias, a
beta blocker drug should be added but it should not be started until
the patient has received an alpha blocker in order to avoid hy-
pertensive crisis caused by unopposed alpha adrenergic receptor
stimulation [19]. In the case described in this report, Atenolol and
Amlodipine were added 5 days after administration of alpha
blockade. So the patient was on phenoxybenzamine, atenolol and
amlodipine for 10 days, aiming for optimal blood pressure control
prior to the surgery. Dosing was tittered according to his blood
pressure readings, which were ranging between 113 and 123/
63e75 mm Hg.
For years, thoracoabdominal approach for the surgical man-
agement of adrenal masses has been utilized. Nowadays, laparo-
scopic adrenalectomy, has been utilized frequently for the surgical
treatment for both adrenal and extra-adrenal [20]. This is also true
for pediatric patients [21]. After total bilateral adrenalectomy, pa-
tients will require prolonged steroid replacement. To avoid
morbidity associated with steroid treatment, adrenal sparing sur-
gery has been utilized successful in the management of bilateral
PCC. In a study, Cortical paring surgery has been done in thirteen
patients with bilateral pheochromocytoma related to multiple
endocrine neoplasia (MEN type 2) or Von-Hippel-Landau disease
with none of them required steroid treatment after surgery.
Although it was found that 3 out of 14 (21%) of patients who un-
derwent this approach, developed recurrent PCC in one series [22].
As in the case we are reporting, adrenal cortex was spared, bilat-
erally so no steroids were used in the postoperative period. Adre-
nocortical function was preserved and patient did not require
steroid in post-operative period following the operation,
Biochemical tests (24-h urinary catecholamine) should be per-
formed and lifelong follow up of urinary catecholamine levels
should be performed to identify recurrent or metachronous pheo-
chromocytoma [23].
3. Conclusion
Although PCC is a rare neoplasm, it should be considered as a
possible diagnosis in children presenting with malignant hyper-
tension. Genetic tests should be done in patients with pheochro-
mocytoma who are young, have a positive family history, and with
bilateral disease. Patients must be treated properly with anti-
hypertensive medications in order to stabilize blood pressure
before surgery. Adrenal sparing surgery has been utilized success-
fully and most patients will not need steroid treatment afterward.
For best outcome surgery should be done in a center where expert
surgeon and anesthesia are available.
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